Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adalimumab (humira) (1 trial)
etanercept (enbrel) (1 trial)
infliximab (remicade) (1 trial)
Trials (1 total)
Trial APIs (3 total)